Clinical Trial 49414

Dallas, TX 75231


The main purpose of this study is to see whether TNX-102 SL can help people with fibromyalgia (FM). TNX-102 SL is the drug cyclobenzaprine in a new sublingual formulation, which means it is designed to be placed under the tongue and allowed to dissolve there

Qualified Participants Must:

• Participants must be Male or Female 18 to 65 years of age and have a diagnosis of primary FM.

Qualified Participants May Receive:

If you qualify, you may receive investigational medication and study-related procedures from a local doctor. Reimbursement for time and travel related to study participation may be provided.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.